Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration - PubMed (original) (raw)
Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration
Y P De Jong et al. Gastroenterology. 2000 Sep.
Abstract
Background & aims: Experimental colitis in most animal models is caused by dysregulation of T lymphocytes that display a T helper 1 (Th1) phenotype. CD154 (CD40L/gp39), a member of the tumor necrosis factor (TNF) family, is up-regulated on T cells on activation and has been shown to play a key role in the induction of a Th1 response. We investigated whether chronic experimental colitis is dependent on the CD154/CD40 pathway and whether disease can be prevented by anti-CD154 antibody treatment.
Methods: Two models of chronic colitis were used: CD45Rb(hi) cell transfer into recombination activation gene-deficient (Rag(-/-)) mice and bone marrow transplant of tgepsilon26 animals. In both models, mice were reconstituted with cells from CD154-deficient animals. In another series of experiments, wild-type CD45Rb(hi) T cell-reconstituted recipients were treated with anti-CD154, either from the start of the experiment or after onset of disease.
Results: T cells deficient in CD154 induced a milder clinical disease, less weight loss, and fewer histologic signs of colitis than wild-type cells. The level of interleukin 12 in the serum of CD154-deficient T-cell recipients was 5-fold less than that of wild-type cell recipients. Nevertheless, no signs of deviation from a Th1 phenotype were observed. Treatment with anti-CD154 antibodies substantially impaired disease development, even when started after the onset of colitis.
Conclusions: The CD154/CD40 pathway plays a critical role in Th1-induced chronic experimental colitis. Blocking CD154, even after the onset of disease, ameliorates colitis but does not induce a T helper 2 (Th2) phenotype.
Similar articles
- Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses.
Kelsall BL, Stüber E, Neurath M, Strober W. Kelsall BL, et al. Ann N Y Acad Sci. 1996 Oct 31;795:116-26. doi: 10.1111/j.1749-6632.1996.tb52660.x. Ann N Y Acad Sci. 1996. PMID: 8958922 - Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions.
Liu Z, Geboes K, Colpaert S, Overbergh L, Mathieu C, Heremans H, de Boer M, Boon L, D'Haens G, Rutgeerts P, Ceuppens JL. Liu Z, et al. J Immunol. 2000 Jun 1;164(11):6005-14. doi: 10.4049/jimmunol.164.11.6005. J Immunol. 2000. PMID: 10820284 - Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12.
Cong Y, Weaver CT, Lazenby A, Elson CO. Cong Y, et al. J Immunol. 2000 Aug 15;165(4):2173-82. doi: 10.4049/jimmunol.165.4.2173. J Immunol. 2000. PMID: 10925304 - The CD154-CD40 costimulatory pathway in transplantation.
Yamada And A, Sayegh MH. Yamada And A, et al. Transplantation. 2002 Jan 15;73(1 Suppl):S36-9. doi: 10.1097/00007890-200201151-00012. Transplantation. 2002. PMID: 11810060 Review. - The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells.
Mackey MF, Barth RJ Jr, Noelle RJ. Mackey MF, et al. J Leukoc Biol. 1998 Apr;63(4):418-28. doi: 10.1002/jlb.63.4.418. J Leukoc Biol. 1998. PMID: 9544571 Review.
Cited by
- Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
Kullberg MC, Rothfuchs AG, Jankovic D, Caspar P, Wynn TA, Gorelick PL, Cheever AW, Sher A. Kullberg MC, et al. Infect Immun. 2001 Jul;69(7):4232-41. doi: 10.1128/IAI.69.7.4232-4241.2001. Infect Immun. 2001. PMID: 11401959 Free PMC article. - The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system.
Becher B, Durell BG, Miga AV, Hickey WF, Noelle RJ. Becher B, et al. J Exp Med. 2001 Apr 16;193(8):967-74. doi: 10.1084/jem.193.8.967. J Exp Med. 2001. PMID: 11304557 Free PMC article. - The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeys.
Nicholson SM, Casey KA, Gunsior M, Drabic S, Iverson W, Cook H, Scott S, O'Day T, Karanth S, Dixit R, Ryan PC. Nicholson SM, et al. Br J Pharmacol. 2020 Mar;177(5):1061-1076. doi: 10.1111/bph.14897. Epub 2020 Feb 3. Br J Pharmacol. 2020. PMID: 31648370 Free PMC article. - The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells.
Khor B, Gagnon JD, Goel G, Roche MI, Conway KL, Tran K, Aldrich LN, Sundberg TB, Paterson AM, Mordecai S, Dombkowski D, Schirmer M, Tan PH, Bhan AK, Roychoudhuri R, Restifo NP, O'Shea JJ, Medoff BD, Shamji AF, Schreiber SL, Sharpe AH, Shaw SY, Xavier RJ. Khor B, et al. Elife. 2015 May 22;4:e05920. doi: 10.7554/eLife.05920. Elife. 2015. PMID: 25998054 Free PMC article. - E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis.
Siddiqui KR, Laffont S, Powrie F. Siddiqui KR, et al. Immunity. 2010 Apr 23;32(4):557-67. doi: 10.1016/j.immuni.2010.03.017. Epub 2010 Apr 15. Immunity. 2010. PMID: 20399121 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials